Our mission is to make disease biology visible earlier.
OUR MISSION
We believe the next era of precision medicine depends on the ability to see molecular biology inside living systems — clearly, quantitatively, and earlier in the development process. ImageNova helps turn biological uncertainty into visual, measurable, translational evidence.
Our mission is to make disease biology visible earlier.
We believe the next era of precision medicine depends on the ability to see molecular biology inside living systems — clearly, quantitatively, and earlier in the development process. ImageNova helps turn biological uncertainty into visual, measurable, translational evidence.
Visible Biology
Unlocking deep insights into living biological systems through high-resolution imaging technology.
Quantitative Evidence
Converting complex biological signals into measurable, validated data points for drug development.
Translational Focus
Bridging the gap between discovery and clinical validation with evidence that supports advancement.
A team built at the intersection of science and translation.
ImageNova brings together experience across immunology, molecular imaging, radiochemistry, theranostics, oncology research, laboratory operations, business development, and biotech translation.
Dr. Mike
Chief Executive Officer
Expert in molecular imaging and theranostics translation, previously leading lab operations at top-tier Silicon Valley research institutions.
Dr. Frank
Head of Radiochemistry
Leading researcher in ligand design and isotope labeling, focusing on high-affinity probes for early-stage tumor detection.
Serena
VP Business Development
Driving strategic partnerships across pharma and oncology sectors, specializing in preclinical data-to-clinic pipeline strategies.
Dr. Chen
Lead Immuno-Oncologist
Focused on tumor microenvironment visibility and target relevance questions, bridging clinical hypotheses with imaging datasets.
How we work.
Our operating principles define how we turn biological uncertainty into visual, measurable, translational evidence.
Visible Biology
Making the invisible visible through precision molecular imaging and advanced biomarker discovery.
Translational Relevance
Bridging the gap between laboratory discovery and patient outcomes through clinical-grade preclinical models.
Quantitative Evidence
Moving beyond qualitative observation to deliver measurable, digital data for drug development decisions.
Scientific Partnership
Acting as an extension of your R&D team, providing deep expertise in radiochemistry and molecular science.
Partner with a team built for molecular evidence.
Whether you are developing a radiopharmaceutical, validating a target, or planning a preclinical imaging study, ImageNova can help move your program from hypothesis to evidence.
Based in Silicon Valley. Built for translational science.
ImageNova operates from San Jose, California, with infrastructure supporting preclinical molecular imaging, radiopharmaceutical research, and in vivo validation studies.
San Jose Preclinical Hub